statistiche ricercatore

Continente	#
AS - Asia	922
NA - Nord America	799
EU - Europa	584
SA - Sud America	124
Continente sconosciuto - Info sul continente non disponibili	31
AF - Africa	24
Totale	2.484

Nazione	#
US - Stati Uniti d'America	744
SG - Singapore	266
VN - Vietnam	235
IT - Italia	177
CN - Cina	161
RU - Federazione Russa	112
HK - Hong Kong	104
BR - Brasile	87
DE - Germania	76
SE - Svezia	40
BD - Bangladesh	38
GB - Regno Unito	37
IE - Irlanda	33
CA - Canada	31
FR - Francia	30
KR - Corea	22
IN - India	21
FI - Finlandia	16
ID - Indonesia	16
MX - Messico	15
ES - Italia	14
AR - Argentina	13
TR - Turchia	12
IQ - Iraq	11
JP - Giappone	11
CH - Svizzera	9
PL - Polonia	9
ZA - Sudafrica	9
CO - Colombia	8
NL - Olanda	8
AT - Austria	7
PK - Pakistan	6
EC - Ecuador	5
UA - Ucraina	5
VE - Venezuela	5
CR - Costa Rica	3
EG - Egitto	3
KE - Kenya	3
MA - Marocco	3
PS - Palestinian Territory	3
UZ - Uzbekistan	3
BO - Bolivia	2
CZ - Repubblica Ceca	2
ET - Etiopia	2
GR - Grecia	2
JM - Giamaica	2
JO - Giordania	2
NP - Nepal	2
PT - Portogallo	2
SA - Arabia Saudita	2
AE - Emirati Arabi Uniti	1
AL - Albania	1
AO - Angola	1
AZ - Azerbaigian	1
BG - Bulgaria	1
BW - Botswana	1
CL - Cile	1
EE - Estonia	1
GE - Georgia	1
GN - Guinea	1
HN - Honduras	1
KZ - Kazakistan	1
LK - Sri Lanka	1
LT - Lituania	1
MQ - Martinica	1
MY - Malesia	1
PA - Panama	1
PH - Filippine	1
PY - Paraguay	1
SI - Slovenia	1
SN - Senegal	1
SR - Suriname	1
SV - El Salvador	1
UY - Uruguay	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	2.454

Nome	#
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis	345
A NOVEL MACHINE-LEARNING, COMMON VARIANTS-BASED APPROACH TO PREDICT PRIMARY BILIARY CHOLANGITIS	297
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid	249
Real-world experience with obeticholic acid in patients with primary biliary cholangitis	232
Eosinophilic esophagitis: does age matter?	224
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis	211
Prognostic scores for ursodeoxycholic acid-treated patients predict graft loss and mortality in recurrent primary biliary cholangitis after liver transplantation	205
Ultrasound muscle assessment for sarcopenia detection in inflammatory bowel disease: A prospective study	205
New insights on the role of human leukocyte antigen complex in primary biliary cholangitis	184
Use of IBD Drugs in Patients with Hepatobiliary Comorbidities: Tips and Tricks	177
Takayasu arteritis and primary sclerosing cholangitis: A casual association or different phenotypes of the same disease?	155
Totale	2.484

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	17	0	0	0	0	0	0	0	9	3	0	2	3
2022/2023	178	6	11	13	15	33	34	10	11	7	13	9	16
2023/2024	183	5	14	18	22	19	37	25	3	9	9	8	14
2024/2025	574	30	49	38	38	50	39	34	9	45	103	73	66
2025/2026	1.490	272	161	108	194	137	68	183	39	85	111	47	85
2026/2027	42	42	0	0	0	0	0	0	0	0	0	0	0
Totale													2.484

Bicocca Open Archive